Diabetic Drugs
- All
- News
- Videos
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Kidney Disease In India: Doctor Explains Why Self-Medication Is A Major Kidney Health Risk
While high blood pressure and diabetes are the major contributors to kidney disease, experts say that there's one more risk factor which leads to kidney diseases in India. This is self- medication.
-
Popular Weight Loss Drugs May Help Reduce Risk of Substance Use Disorders, Suggests New Study
A new study published in The BMJ says that GLP-1 drugs may help prevent and treat substance use disorders across all major addictive substances that were studied.
-
Jan Aushadhi Kendra In Jamtara Provides Affordable Medicines To Poor, Middle-Class People, Drawing Over 200 Patients Daily
The Jan Aushadhi Kendra located near Veer Kunwar Chowk in Jamtara district of Jharkhand, is fast emerging as a major relief for poor and middle-class people, ensuring that affordable and quality medicines reach the general public.
-
World Birth Defects Day: Why India Bears A High Burden Of Congenital Anomalies
On World Birth Defects Day, India's congenital anomalies burden is spotlighted with roughly 472,000 affected births annually, contributing to high neonatal mortality and disability.
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Tanmay Bhat Admits To Using Weight Loss Drugs: Why It Isn't Working For Him
GLP-1 drugs are highly effective, FDA-approved medications for managing type 2 diabetes
-
Living In High Altitude Protects Against Diabetes, Scientists Discover Why
Diabetes reversed in mice with a pill mimicking high altitude hypoxia. Scientists say red blood cells hold the key.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Kidney Disease In India: Doctor Explains Why Self-Medication Is A Major Kidney Health Risk
While high blood pressure and diabetes are the major contributors to kidney disease, experts say that there's one more risk factor which leads to kidney diseases in India. This is self- medication.
-
Popular Weight Loss Drugs May Help Reduce Risk of Substance Use Disorders, Suggests New Study
A new study published in The BMJ says that GLP-1 drugs may help prevent and treat substance use disorders across all major addictive substances that were studied.
-
Jan Aushadhi Kendra In Jamtara Provides Affordable Medicines To Poor, Middle-Class People, Drawing Over 200 Patients Daily
The Jan Aushadhi Kendra located near Veer Kunwar Chowk in Jamtara district of Jharkhand, is fast emerging as a major relief for poor and middle-class people, ensuring that affordable and quality medicines reach the general public.
-
World Birth Defects Day: Why India Bears A High Burden Of Congenital Anomalies
On World Birth Defects Day, India's congenital anomalies burden is spotlighted with roughly 472,000 affected births annually, contributing to high neonatal mortality and disability.
-
Abbott, Novo Nordisk India Partner Up To Launch Second Brand Of Ozempic, Widen Access To Diabetes Drug
Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, Extensior, in India
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Tanmay Bhat Admits To Using Weight Loss Drugs: Why It Isn't Working For Him
GLP-1 drugs are highly effective, FDA-approved medications for managing type 2 diabetes
-
Living In High Altitude Protects Against Diabetes, Scientists Discover Why
Diabetes reversed in mice with a pill mimicking high altitude hypoxia. Scientists say red blood cells hold the key.
